A cholesterol breakthrough medication just became available. Lipfendra (enlicitide) is a groundbreaking prescription medication from Merck that was approved by the FDA in July 2026 as the world's first once-daily oral pill to lower bad cholesterol (LDL-C). It works by blocking the PCSK9 protein, which helps the liver aggressively clear cholesterol from the bloodstream. This daily tablet offers a highly effective, needle-free alternative for patients who previously had to rely on painful bi-weekl

The Link Between Fatty Liver Disease and Viral Hepatitis

Why Two Patients with the Same Cancer May Receive Different Treatment

🚀 40+ Coding Problems & a Website in Just 7 Days! 🤯 | 19MAcademy